HealthRX review
Publishes its entire term ladder as machine-readable data — and advertises the twelve-month rung, so the price on the tin is roughly half the price you pay month to month.
- Semaglutide
- $190/mo (all doses, compounded)
- Tirzepatide
- $239/mo (all doses, compounded)
- Coverage
- All 50 states
- Brand-name
- Compounded only
Semaglutide · modeled / year
$2,280
Tirzepatide · modeled / year
$2,868
The Index scorecard
HealthRX scored on our six Cost-Efficiency Index factors. See the methodology.
Where the value is
- All 50 states, printed in the site's own header strip rather than left to the intake quiz
- Specific, checkable LegitScript certificate number (50087439) rather than just a generic badge image
- "Same price at every dose" policy avoids dose-based price creep
- Publishes every rung of both ladders as machine-readable Offer data, so the full term structure is checkable rather than inferred
- Consult, prescription, medication and overnight shipping are all included — no membership or visit fee stacked on top
- Cancel online in one click, a full refund if a provider does not approve you, and a 30-day money-back guarantee
The tradeoffs
- The advertised $99 and $179 are twelve-month prepay rungs — $1,188 and $2,148 up front. The standing month-to-month rates are $190 and $239, roughly double and a third higher
- A second discount is stacked on the same headline: $99 semaglutide and $149 tirzepatide are also first-month intro rates on the monthly plan, so month two costs more than month one
- No medical director named
- The specific compounding pharmacy is not disclosed — only "a licensed Section 503A compounding pharmacy"
- No physician names or clinical team bios published anywhere on the site
- Compounded semaglutide and tirzepatide are not FDA-approved and are not Wegovy, Ozempic or Zepbound; no brand-name lane is offered
The bottom line
Best for: Shoppers who want the whole term ladder published before intake and are reading it carefully enough to spot which rung the headline came from. Publishes its entire term ladder as machine-readable data — and advertises the twelve-month rung, so the price on the tin is roughly half the price you pay month to month.
Ranked #38 of 505 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.
Compare with other providers
All 504 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to HealthRX.
- #42NiceRx— NiceRx is a compounded GLP-1 telehealth platform charging $199/mo for semaglutide and $299/mo for tirzepatide on an ongoing month-to-month basis (first month discounted to $99 and $199 respectively),…76/100
- #43Vytora Health— Vytora Health (Wasef Health, PC) is a 50-state-plus-DC telehealth platform selling flat-rate compounded semaglutide and tirzepatide alongside retail-priced brand-name Mounjaro and Zepbound ($1,399/mo each).76/100
- #44Rylo Health— Rylo Health is a compounded GLP-1/NAD+/peptide telehealth platform operating in all 50 states through Lone Star Virtual Health PLLC and dispensing via VialsRX in Houston, TX.75/100
- #45Peter MD— One account across six verticals — TRT, ED, weight loss, GLP-1, men's hair loss and NAD+ — from a physician-prescribed telehealth brand running since 2021, at a renewal price ($249/mo tirzepatide) well above its own $149 first-month headline.72/100
- #46EdgeRx— The best clinical documentation of any newly added row — a named Chief Medical Advisor and a named 503A pharmacy — but it's a men's-only platform, not a fit for every reader.74/100
- #47Amble— Amble is a managed-services telehealth platform (by its own terms, not itself a medical facility or pharmacy) selling compounded semaglutide and tirzepatide at IDENTICAL prices on a commitment-length…74/100
The 18 programs nearest this one
Pricing, states and verification reflect HealthRX's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on HealthRX's site. Not medical advice; see our disclosure.